Shares of Tharimmune Inc (NASDAQ:THAR) are surging Thursday afternoon after the company on Wednesday announced positive results from a simulation analysis of its lead clinical asset, TH104. What To Kn[...]
By using this site, you agree to the storage of cookies on your device for enhanced navigation, site analysis, and The TradingPub's marketing. Data sharing with social media platforms might occur based on the privacy choices you make on those platforms. For specifics, see our Privacy Policy.OkPrivacy policy
